Shared on15 Aug 25Fair value Increased 11%
Enovix's price target was raised to $29.50 as analysts cited strong Q2 results, new product launches in advanced battery technology, and shareholder-friendly capital moves, though some caution valuation after a sharp share price rally. Analyst Commentary Bullish analysts cite robust preliminary Q2 and June results, with revenue and adjusted EBITDA beating expectations, primarily driven by the Korean divisions.
Shared on17 Apr 25Fair value Decreased 1.77%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.